🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the tolerability of topical combina...
Status
Completed
Location
Centro de Investigación y Prevencion de Enfermidades Cardiovasculares
Start Date
2009-02
Trial ID
NCT00887484
Treatments Being Tested
This is a randomized, double-blind, multiple-site, placebo-controlled, para...
Status
Completed
Location
Glenmark Investigational Site 13
Start Date
2015-04
Trial ID
NCT02465632
This study is to evaluate the therapeutic equivalence and safety of Taro Pr...
Status
Completed
Location
Catawba Research, LLC
Start Date
2019-03-20
Trial ID
NCT04134273
Treatments Being Tested
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulg...
Status
Completed
Location
Catawba Research LLC
Start Date
2019-09-09
Trial ID
NCT04321070
Treatments Being Tested
Randomized, Parallel Group, Active Controlled Trial to compare effectivenes...
Status
Completed
Location
BJ Govt. Medical College & Sassoon General Hospitals, Pune
Start Date
2011-04
Trial ID
NCT01697826
Treatments Being Tested
Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl...
Status
Completed
Location
Alliance Dermatology
Start Date
2015-05
Trial ID
NCT02616614
Treatments Being Tested
In this study, patients who have had previous endoscopic sinus surgery and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06
Trial ID
NCT03935828
Treatments Being Tested
This research is being done to find out the safety and efficacy of two acne...
Status
Completed
Location
Penn State Hershey Medical Center
Start Date
2010-10
Trial ID
NCT01237821
This study is to evaluate the therapeutic equivalence and safety of Clindam...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02595034
Treatments Being Tested
ZIANA® (clindamycin phosphate 1.2% and tretinoin 0.025%) gel, marketed by M...
Status
Completed
Location
Lotus Labs Pvt. Ltd
Start Date
2010-05
Trial ID
NCT01257906
Treatments Being Tested